IPD 3.08% 6.7¢ impedimed limited

I don't think we can conclude the tape measure group had more...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 27 Posts.
    lightbulb Created with Sketch. 13
    I don't think we can conclude the tape measure group had more false positives - it had more progressions to CDP which essentially indicate clinical progression i.e. a true positive.

    We can ethier conclude that intervening with the BIS L-DEX criteria may lead to less CDP progressions than vs the tape measure criteria, or that the BIS group was actually catching out less patients for early intervention i.e. providing false negatives (remember no matter how swollen the limbs get the BIS group would not actually catch them out unless the L-Dex is above threshold). But none of this is statistically significant and we don't know how well the diagnosis works yet.

    Really like the idea of early intervention/prevention of lyphemdema onset and I think this could be a lot bigger than 20 mil - but need a bit more evidence in terms of statistical significance and accuracy of diagnostics. very spec buy atm for me. Anyone know when the next set of data comes out?
 
watchlist Created with Sketch. Add IPD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.